you are here:

Dr Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE089A01023 | SECTOR: Pharmaceuticals

BSE Live

Dec 03, 16:00
4924.50 75.15 (1.55%)
Volume
AVERAGE VOLUME
5-Day
46,032
10-Day
51,068
30-Day
57,555
67,038
  • Prev. Close

    4849.35

  • Open Price

    4853.30

  • Bid Price (Qty.)

    4924.50 (58)

  • Offer Price (Qty.)

    4945.00 (25)

NSE Live

Dec 03, 15:58
4923.05 72.80 (1.50%)
Volume
AVERAGE VOLUME
5-Day
1,409,302
10-Day
1,650,275
30-Day
1,699,178
1,034,893
  • Prev. Close

    4850.25

  • Open Price

    4870.00

  • Bid Price (Qty.)

    4923.05 (1259)

  • Offer Price (Qty.)

    0.00 (0)

Financials

2019 2018 2017 2016 2015
Quarterly Results of Dr Reddys Laboratories (in Rs. Cr.) Sep '20 Jun '20 Mar '20 Dec '19 Sep '19  
Net Sales/Income from operations 3,333.60 3,236.80 2,837.90 3,044.00 3,446.00  
Other Operating Income 12.20 7.60 13.80 -- --  
Total Income From Operations 3,345.80 3,244.40 2,851.70 3,044.00 3,446.00  
EXPENDITURE  
Consumption of Raw Materials 816.50 788.20 654.30 673.00 645.30  
Purchase of Traded Goods 304.30 300.30 226.10 346.10 297.10  
Increase/Decrease in Stocks -135.80 -192.90 67.20 -100.10 0.50  
Power & Fuel -- -- -- -- --  
Employees Cost 608.00 545.00 516.60 511.20 502.80  
depreciat 214.20 197.70 192.30 195.80 204.10  
Excise Duty -- -- -- -- --  
Admin. And Selling Expenses 936.20 -- -- -- --  
R & D Expenses -- -- -- -- --  
Provisions And Contingencies -- -- -- -- --  
Exp. Capitalised -- -- -- -- --  
Other Expenses -- 875.10 866.70 858.10 839.50  
P/L Before Other Inc. , Int., Excpt. Items & Tax 602.40 731.00 328.50 559.90 956.70  
Other Income 26.60 644.70 127.40 69.30 76.70  
P/L Before Int., Excpt. Items & Tax 629.00 1,375.70 455.90 629.20 1,033.40  
Interest 9.30 14.00 11.80 11.70 12.20  
P/L Before Exceptional Items & Tax 619.70 1,361.70 444.10 617.50 1,021.20  
Exceptional Items -- -- -- -- --  
P/L Before Tax 619.70 1,361.70 444.10 617.50 1,021.20  
Tax 138.70 411.50 -58.70 95.80 -343.90  
P/L After Tax from Ordinary Activities 481.00 950.20 502.80 521.70 1,365.10  
Prior Year Adjustments -- -- -- -- --  
Extra Ordinary Items -- -- -- -- --  
Net Profit/(Loss) For the Period 481.00 950.20 502.80 521.70 1,365.10  
Equity Share Capital 83.10 83.10 83.10 83.10 83.10  
Reserves Excluding Revaluation Reserves -- -- -- -- --  
Equity Dividend Rate (%) -- -- -- -- --  
EPS Before Extra Ordinary  
Basic EPS 29.00 57.31 30.34 31.47 82.36  
Diluted EPS 28.92 57.18 30.28 31.42 82.24  
EPS After Extra Ordinary  
Basic EPS. 29.00 57.31 30.34 31.47 82.36  
Diluted EPS. 28.92 57.18 30.28 31.42 82.24  
Public Share Holding  
No Of Shares (Crores) -- -- -- -- --  
Share Holding (%) -- -- -- -- --  
Promoters and Promoter Group Shareholding  
a) Pledged/Encumbered  
- Number of shares (Crores) -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --  
b) Non-encumbered  
- Number of shares (Crores). -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group). -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company). -- -- -- -- --  
Source : Dion Global Solutions Limited

Results of Dr Reddys Labs